← Browse by Condition
Medical Condition

acute lymphoblastic leukemia refractory

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04881240 Phase 1
Recruiting

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Enrollment
60 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →